From Belgium to the US, World Leaders in Biotech

Add this event to your calendar:
04/06/2013 11:30 04/06/2013 17:30 America/Los_Angeles From Belgium to the US, World Leaders in Biotech Janssen Research & Development , 3210 Merryfield Row , San Diego , CA 92121 JLABS San Diego together with Janssen R&D false DD/MM/YYYY
June
4
Event

From Belgium to the US, World Leaders in Biotech

Janssen Research & Development , 3210 Merryfield Row , San Diego , CA 92121

June 04, 2013 from 11:30 AM to 17:30 PM (PST)

$10 - $35


Program Overview:
You are cordially invited to hear from top executives from selected Belgian life science organizations, government agencies and biotech startups. If you are looking to find out more about Europe's hotbed in biotech, Belgium is the place to look. Historically a key region for pharmaceuticals, with the fastest Phase 1 approval process and the highest number of clinical trials per capita of Europe, Belgium has become a world renowned place where biotech and biopharma breakthroughs are translated into successful companies.

Agenda:
9:30am | Registration & Coffee

10:00am | Welcome 
          Diego Miralles, Head of Janssen R&D Center San Diego and Janssen Labs
          Duane Roth, CEO, CONNECT
          Tom Heyman, CEO and Chairman, Janssen Pharmaceutica
          Claire Tillekaerts, CEO FLANDERS INVESTMENT AND TRADE


10:45am | Guided Tour of Janssen Labs


11:30am | Networking Lunch


12:30pm | Presentations 
          Introduction
          H.E. Jean-Claude Marcourt
, VP of the Government of Wallonia & Minister of
               Economy
          
          Belgium, the Place to Be For Biopharmaceutical R&D and Manufacturing
          Yves Verschueren
, Managing Director, essenscia
         
          The San Diego Biotech Scene
          Magda Marquet, Chair of the Board of Directors, BIOCOM   

         
VIB - the Center of Excellence in Life Science Research in Flanders
         
Johan Cardoen, Managing Director VIB, Flemish Institute for Biotechnology
         
          The Biotech Cluster in Wallonia
         
France Fannes, Managing Director, BioWin

1:30pm | Belgian and US Biotech Company Presentations
          Disease-modifying Treatments Against Alzheimer's, Parkison's, Diabetes
               and Other Protein Misfolding Disorders
          Koen De Witte, CEO, ReMynd

          Novel Approaches to Treating Alzheimer’s and Parkinson’s Disease
          Michel Levesque & Mohamedi Kagalwala, NeuroGeneration

          Trusted and Innovative Solutions for Diagnostics and Biopharmaceuticals
          Luc Marion, Senior Manager Diagnostic Services, Eurogentec

          Next Generation Vision Correcting Treatment
               and other Protein misfolding Disorders
          Alberto Osio, CEO, Yolia Health

          Amgen, Nobel Prize chemistry 2012 and Many Other Californian Partners:
               Pillars of the UCB Innovation Model
          Didier Malherbe, Vice President UCB and General Manager UCB Belgium
          
2:30pm | Reception

3:30pm | Close

Location:
Janssen Research & Development LLC
3210 Merryfield Row
San Diego, CA 92121

*Registration is limited, please register early* 


JLABS San Diego together with Janssen R&D

Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and healthtech sectors. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then has grown to ten global locations including the Bay Area, Boston & Lowell, MA, Houston, Toronto, Beerse (Belgium), with New York City, opening in June 2018, and Shanghai in 2019. For more information please visit www.jlabs.jnjinnovation.com or follow @JLABS.

Event contact


Related content